{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:14:07Z","timestamp":1791886447500,"version":"4.3.4"},"reference-count":73,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Danish health authorities (SST)","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}]},{"name":"Danish health authorities (SST)","award":["101041231"],"award-info":[{"award-number":["101041231"]}]},{"name":"Danish health authorities (SST)","award":["101057438"],"award-info":[{"award-number":["101057438"]}]},{"name":"Danish health authorities (SST)","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}]},{"name":"Danish health authorities (SST)","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}]},{"name":"Danish health authorities (SST)","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}]},{"name":"Danish health authorities (SST)","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}]},{"name":"Danish health authorities (SST)","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}]},{"name":"Danish health authorities (SST)","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}]},{"name":"Danish health authorities (SST)","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}]},{"name":"Danish health authorities (SST)","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}]},{"name":"Danish health authorities (SST)","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}]},{"name":"Danish health authorities (SST)","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}]},{"name":"EU Commission","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}]},{"name":"EU Commission","award":["101041231"],"award-info":[{"award-number":["101041231"]}]},{"name":"EU Commission","award":["101057438"],"award-info":[{"award-number":["101057438"]}]},{"name":"EU Commission","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}]},{"name":"EU Commission","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}]},{"name":"EU Commission","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}]},{"name":"EU Commission","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}]},{"name":"EU Commission","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}]},{"name":"EU Commission","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}]},{"name":"EU Commission","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}]},{"name":"EU Commission","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}]},{"name":"EU Commission","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}]},{"name":"EU Commission","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}]},{"name":"Horizon Research and Innovation Actions","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}]},{"name":"Horizon Research and Innovation Actions","award":["101041231"],"award-info":[{"award-number":["101041231"]}]},{"name":"Horizon Research and Innovation Actions","award":["101057438"],"award-info":[{"award-number":["101057438"]}]},{"name":"Horizon Research and Innovation Actions","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}]},{"name":"Horizon Research and Innovation Actions","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}]},{"name":"Horizon Research and Innovation Actions","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}]},{"name":"Horizon Research and Innovation Actions","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}]},{"name":"Horizon Research and Innovation Actions","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}]},{"name":"Horizon Research and Innovation Actions","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}]},{"name":"Horizon Research and Innovation Actions","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}]},{"name":"Horizon Research and Innovation Actions","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}]},{"name":"Horizon Research and Innovation Actions","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}]},{"name":"Horizon Research and Innovation Actions","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["101041231"],"award-info":[{"award-number":["101041231"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["101057438"],"award-info":[{"award-number":["101057438"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["101041231"],"award-info":[{"award-number":["101041231"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["101057438"],"award-info":[{"award-number":["101057438"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}],"id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["101041231"],"award-info":[{"award-number":["101041231"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["101057438"],"award-info":[{"award-number":["101057438"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["101041231"],"award-info":[{"award-number":["101041231"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["101057438"],"award-info":[{"award-number":["101057438"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["101041231"],"award-info":[{"award-number":["101041231"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["101057438"],"award-info":[{"award-number":["101057438"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}],"id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agnes og Poul Friis Fond","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}]},{"name":"Agnes og Poul Friis Fond","award":["101041231"],"award-info":[{"award-number":["101041231"]}]},{"name":"Agnes og Poul Friis Fond","award":["101057438"],"award-info":[{"award-number":["101057438"]}]},{"name":"Agnes og Poul Friis Fond","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}]},{"name":"Agnes og Poul Friis Fond","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}]},{"name":"Agnes og Poul Friis Fond","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}]},{"name":"Agnes og Poul Friis Fond","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}]},{"name":"Agnes og Poul Friis Fond","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}]},{"name":"Agnes og Poul Friis Fond","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}]},{"name":"Agnes og Poul Friis Fond","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}]},{"name":"Agnes og Poul Friis Fond","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}]},{"name":"Agnes og Poul Friis Fond","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}]},{"name":"Agnes og Poul Friis Fond","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["101041231"],"award-info":[{"award-number":["101041231"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["101057438"],"award-info":[{"award-number":["101057438"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}]},{"name":"Slagtermester Max W\u00f8rzner og Hustru Inger W\u00f8rzners Mindelegat","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}]},{"name":"AP M\u00f8ller Foundation","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}]},{"name":"AP M\u00f8ller Foundation","award":["101041231"],"award-info":[{"award-number":["101041231"]}]},{"name":"AP M\u00f8ller Foundation","award":["101057438"],"award-info":[{"award-number":["101057438"]}]},{"name":"AP M\u00f8ller Foundation","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}]},{"name":"AP M\u00f8ller Foundation","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}]},{"name":"AP M\u00f8ller Foundation","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}]},{"name":"AP M\u00f8ller Foundation","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}]},{"name":"AP M\u00f8ller Foundation","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}]},{"name":"AP M\u00f8ller Foundation","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}]},{"name":"AP M\u00f8ller Foundation","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}]},{"name":"AP M\u00f8ller Foundation","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}]},{"name":"AP M\u00f8ller Foundation","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}]},{"name":"AP M\u00f8ller Foundation","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}]},{"name":"Riisfort Foundation","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}]},{"name":"Riisfort Foundation","award":["101041231"],"award-info":[{"award-number":["101041231"]}]},{"name":"Riisfort Foundation","award":["101057438"],"award-info":[{"award-number":["101057438"]}]},{"name":"Riisfort Foundation","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}]},{"name":"Riisfort Foundation","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}]},{"name":"Riisfort Foundation","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}]},{"name":"Riisfort Foundation","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}]},{"name":"Riisfort Foundation","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}]},{"name":"Riisfort Foundation","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}]},{"name":"Riisfort Foundation","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}]},{"name":"Riisfort Foundation","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}]},{"name":"Riisfort Foundation","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}]},{"name":"Riisfort Foundation","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}]},{"name":"Synthego","award":["4-1612-391\/1"],"award-info":[{"award-number":["4-1612-391\/1"]}]},{"name":"Synthego","award":["101041231"],"award-info":[{"award-number":["101041231"]}]},{"name":"Synthego","award":["101057438"],"award-info":[{"award-number":["101057438"]}]},{"name":"Synthego","award":["R238-2016-3349"],"award-info":[{"award-number":["R238-2016-3349"]}]},{"name":"Synthego","award":["R303-2018-3571"],"award-info":[{"award-number":["R303-2018-3571"]}]},{"name":"Synthego","award":["0134-00113B"],"award-info":[{"award-number":["0134-00113B"]}]},{"name":"Synthego","award":["0242-00009B"],"award-info":[{"award-number":["0242-00009B"]}]},{"name":"Synthego","award":["9144-00001B"],"award-info":[{"award-number":["9144-00001B"]}]},{"name":"Synthego","award":["NNF19OC0058238"],"award-info":[{"award-number":["NNF19OC0058238"]}]},{"name":"Synthego","award":["NNF21OC0071259"],"award-info":[{"award-number":["NNF21OC0071259"]}]},{"name":"Synthego","award":["8056-00010B"],"award-info":[{"award-number":["8056-00010B"]}]},{"name":"Synthego","award":["CF20-0424"],"award-info":[{"award-number":["CF20-0424"]}]},{"name":"Synthego","award":["CF17-0129"],"award-info":[{"award-number":["CF17-0129"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Following the success of the anti-CD19 chimeric antigen receptor (CAR) T-cell therapies against B-cell malignancies, the CAR T-cell approach is being developed towards other malignancies like acute myeloid leukemia (AML). Treatment options for relapsed AML patients are limited, and the upregulation of the FMS-like tyrosine kinase 3 (FLT3) in malignant T-cells is currently not only being investigated as a prognostic factor, but also as a target for new treatment options. In this review, we provide an overview and discuss different approaches of current anti-FLT3 CAR T-cells under development. In general, these therapies are effective both in vitro and in vivo, however the safety profile still needs to be further investigated. The first clinical trials have been initiated, and the community now awaits clinical evaluation of the approach of targeting FLT3 with CAR T-cells.<\/jats:p>","DOI":"10.3390\/biomedicines10102441","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:07:43Z","timestamp":1665187663000},"page":"2441","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Recent Advances in the Development of Anti-FLT3 CAR T-Cell Therapies for Treatment of AML"],"prefix":"10.3390","volume":"10","author":[{"given":"Maya Graham","family":"Pedersen","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology, Aarhus University Hospital, 8200 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2808-4755","authenticated-orcid":false,"given":"Bjarne Kuno","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Aarhus University Hospital, 8200 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7383-0297","authenticated-orcid":false,"given":"Rasmus O.","family":"Bak","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1073\/pnas.86.24.10024","article-title":"Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity","volume":"86","author":"Gross","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ymthe.2016.10.020","article-title":"Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma","volume":"25","author":"Locke","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_5","unstructured":"(2022, June 15). CAR T Cells: Engineering Patients\u2019 Immune Cells to Treat Their Cancers, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/research\/car-t-cells."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jha2.338","article-title":"Overview of approved CAR-T therapies, ongoing clinical trials, and its impact on clinical practice","volume":"3","author":"Sengsayadeth","year":"2022","journal-title":"eJHaem"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ivica, N.A., and Young, C.M. (2021). Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997\u20132020). Healthcare, 9.","DOI":"10.20944\/preprints202107.0198.v1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute Myeloid Leukemia","volume":"373","author":"Dohner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.emc.2014.04.004","article-title":"Acute leukemia","volume":"32","author":"Kuehl","year":"2014","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Estey","year":"2017","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1182\/blood-2014-05-578070","article-title":"Differential impact of allelic ratio and insertion site in FLT3-ITD\u2013positive AML with respect to allogeneic transplantation","volume":"124","author":"Schlenk","year":"2014","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1016\/j.clml.2018.08.002","article-title":"Improved Survival of Elderly-fit Patients With Acute Myeloid Leukemia Requiring Intensive Therapy: 3-Year Multicenter Analysis From TALWG","volume":"18","author":"Owattanapanich","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/bjh.15799","article-title":"Clinical and biological features of paediatric acute myeloid leukaemia ( AML ) with primary induction failure in the Japanese Paediatric Leukaemia\/Lymphoma Study Group AML-05 study","volume":"185","author":"Miyamura","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00432-017-2429-z","article-title":"Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: A systematic review and meta-analysis","volume":"143","author":"Zhang","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_15","unstructured":"(2022, June 15). Surveillance, Epidemiology, and End Results (SEER) Program Populations. AML (2012\u20132018), Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1016\/S2352-3026(15)00148-9","article-title":"Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: A time-dependent analysis","volume":"2","author":"Versluis","year":"2015","journal-title":"Lancet Haematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1200\/JCO.2015.63.3826","article-title":"Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?","volume":"34","author":"Araki","year":"2016","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.181.5.1653","article-title":"Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes","volume":"181","author":"Brocker","year":"1995","journal-title":"J. Exp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"eaba7308","DOI":"10.1126\/scitranslmed.aba7308","article-title":"A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1038\/s41598-022-14523-0","article-title":"The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.celrep.2017.09.015","article-title":"Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent","volume":"21","author":"Mukherjee","year":"2017","journal-title":"Cell Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1158\/1078-0432.CCR-18-2559","article-title":"Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor\u2013engineered T Cells","volume":"25","author":"Drent","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00018-021-04089-x","article-title":"Tuning the ignition of CAR: Optimizing the affinity of scFv to improve CAR-T therapy","volume":"79","author":"Duan","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"eaat6753","DOI":"10.1126\/scisignal.aat6753","article-title":"Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function","volume":"11","author":"Salter","year":"2018","journal-title":"Sci. Signal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41571-021-00530-z","article-title":"A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains","volume":"18","author":"Cappell","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ymthe.2018.01.022","article-title":"In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia","volume":"26","author":"Cheng","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.15195","article-title":"Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BB","volume":"181","author":"Li","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41375-018-0009-0","article-title":"CAR T-cells targeting FLT3 have potent activity against FLT3\u2212ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib","volume":"32","author":"Jetani","year":"2018","journal-title":"Leukemia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/leu.2017.147","article-title":"Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia","volume":"31","author":"Chen","year":"2017","journal-title":"Leukemia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/toxsci\/kfaa098","article-title":"Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid Leukemia","volume":"177","author":"Karbowski","year":"2020","journal-title":"Toxicol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.ymthe.2020.06.022","article-title":"Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery","volume":"28","author":"Sommer","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-018-0603-7","article-title":"Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells","volume":"11","author":"Wang","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-022-01541-9","article-title":"A novel approach for relapsed\/refractory FLT3(mut+) acute myeloid leukaemia: Synergistic effect of the combination of bispecific FLT3scFv\/NKG2D-CAR T cells and gilteritinib","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Maiorova, V., Mollaev, M.D., Vikhreva, P., Kulakovskaya, E., Pershin, D., Chudakov, D.M., Kibardin, A., Maschan, M.A., and Larin, S. (2021). Natural Flt3Lg-Based Chimeric Antigen Receptor (Flt3-CAR) T Cells Successfully Target Flt3 on AML Cell Lines. Vaccines, 9.","DOI":"10.3390\/vaccines9111238"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ccell.2017.09.004","article-title":"Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML","volume":"32","author":"Perna","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Maucher, M., Srour, M., Danhof, S., Einsele, H., Hudecek, M., and Yakoub-Agha, I. (2021). Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia. Cancers, 13.","DOI":"10.3390\/cancers13246157"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.18632\/oncotarget.13700","article-title":"The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors","volume":"8","author":"Lim","year":"2016","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.4049\/jimmunol.180.11.7358","article-title":"Human Flt3 Is Expressed at the Hematopoietic Stem Cell and the Granulocyte\/Macrophage Progenitor Stages to Maintain Cell Survival","volume":"180","author":"Kikushige","year":"2008","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood.V88.9.3383.bloodjournal8893383","article-title":"FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells","volume":"88","author":"Turner","year":"1996","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","article-title":"The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Medina, K.L. (2022). Flt3 Signaling in B Lymphocyte Development and Humoral Immunity. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137289"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.31557\/APJCP.2021.22.10.3245","article-title":"Frequency of FLT3 Internal Tandem Duplications in Adult Syrian Patients with Acute Myeloid Leukemia and Normal Karyotype","volume":"22","author":"Wafa","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1182\/blood-2002-05-1440","article-title":"Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: A study of the AML Study Group Ulm","volume":"100","author":"Schlenk","year":"2002","journal-title":"Blood"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.leu.2401130","article-title":"Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product","volume":"12","author":"Kiyoi","year":"1998","journal-title":"Leukemia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"612880","DOI":"10.3389\/fonc.2020.612880","article-title":"FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies","volume":"10","author":"Kennedy","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40164-021-00207-4","article-title":"Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns","volume":"10","author":"Guan","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/modpathol.2012.88","article-title":"Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients","volume":"25","author":"Warren","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_53","first-page":"7233","article-title":"Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study","volume":"61","author":"Whitman","year":"2001","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2007-05-091215","article-title":"Prognostic relevance of FLT3-TKD mutations in AML: The combination matters\u2014An analysis of 3082 patients","volume":"111","author":"Bacher","year":"2008","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2011-01-329532","article-title":"Structural insights into the extracellular assembly of the hematopoietic Flt3 signaling complex","volume":"118","author":"Verstraete","year":"2011","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1097-2765(03)00505-7","article-title":"The Structural Basis for Autoinhibition of FLT3 by the Juxtamembrane Domain","volume":"13","author":"Griffith","year":"2004","journal-title":"Mol. Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/gcc.21975","article-title":"Diversity of the juxtamembrane and TKD1 mutations (Exons 13-15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological data","volume":"51","author":"Schnittger","year":"2012","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/leu.2011.372","article-title":"Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia","volume":"26","author":"Hofmann","year":"2012","journal-title":"Leukemia"},{"key":"ref_59","first-page":"111","article-title":"Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase","volume":"90","author":"Rappold","year":"1997","journal-title":"Blood"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.leu.2403825","article-title":"Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth","volume":"19","author":"Williams","year":"2005","journal-title":"Leukemia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1074\/mcp.RA119.001504","article-title":"Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines","volume":"19","author":"Cloos","year":"2020","journal-title":"Mol. Cell. Proteom."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1158\/1535-7163.MCT-19-1093","article-title":"Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia","volume":"19","author":"Brauchle","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"ref_63","unstructured":"(2022, June 15). U.S. National Library of Medicine, Available online: Clinicaltrials.gov."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/2326-6066.CIR-18-0466","article-title":"IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype","volume":"7","author":"Alizadeh","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.2020006921","article-title":"CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy","volume":"137","author":"Willier","year":"2021","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/bcj.2014.39","article-title":"Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia","volume":"4","author":"Ehninger","year":"2014","journal-title":"Blood Cancer J."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Weisberg, E., Ray, A., Nelson, E., Adamia, S., Barrett, R., Sattler, M., Zhang, C., Daley, J.F., Frank, D., and Fox, E. (2011). Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing Cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025351"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00277-002-0535-7","article-title":"Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy","volume":"81","author":"Bojko","year":"2002","journal-title":"Ann. Hematol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1902688","article-title":"Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML","volume":"381","author":"Perl","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Barros, L., Paix\u00e3o, E., Valli, A., Naozuka, G., Fassoni, A., and Almeida, R. (2021). CARTmath\u2014A Mathematical Model of CAR-T Immunotherapy in Preclinical Studies of Hematological Cancers. Cancers, 13.","DOI":"10.20944\/preprints202103.0625.v1"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Mooney, C.J., Cunningham, A., Tsapogas, P., Toellner, K.-M., and Brown, G. (2017). Selective Expression of Flt3 within the Mouse Hematopoietic Stem Cell Compartment. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18051037"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3324\/haematol.2019.233882","article-title":"Genome editing of donor-derived T-cells to generate allogenic chimeric antigen receptor-modified T cells: Optimizing \u03b1\u03b2 T cell-depleted haploidentical hematopoietic stem cell transplantation","volume":"106","author":"Wiebking","year":"2020","journal-title":"Haematologica"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bjh.15851","article-title":"Therapeutic gene editing in haematological disorders with CRISPR\/Cas9","volume":"185","author":"Jensen","year":"2018","journal-title":"Br. J. Haematol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2441\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:44:16Z","timestamp":1760143456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":73,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["biomedicines10102441"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10102441","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]}}}